1 of 26

Course: Oncology Nursing

Topic: Nursing Management of

Oncological Emergency- SIADH

The Nurses International Community

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2024 Nurses International (NI) and the Academic Network. All rights reserved.

2 of 26

COPYRIGHT

© 2013-2024 Nurses International (NI). All rights reserved. No copying without permission. Members of the Academic Network share full proprietary rights while membership is maintained.

NI Privacy Policy and Terms of Use.

Contact info: info@nursesinternational.org

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2024 Nurses International (NI) and the Academic Network. All rights reserved.

3 of 26

Module Goals

Learners will be able to:

  • Explain the underlying pathophysiology of SIADH.
  • Describe the scope of the problem including the incidence, etiology and risk factors for this oncologic emergency.
  • List the clinical manifestations that are associated with this emergency situation.
  • Explain the nursing assessment for SIADH including relevant diagnostic tests.
  • Characterize the nursing interventions and supportive care important to address this problem in a timely and effective manner.

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2024 Nurses International (NI) and the Academic Network. All rights reserved.

4 of 26

Syndrome of Inappropriate Antidiuretic Hormone(SIADH)

  • Syndrome of inappropriate antidiuretic hormone (SIADH) is a group of symptoms that develop when there is too much antidiuretic hormone (ADH) in the body.
  • Results from the inappropriate production and secretion of antidiuretic hormone (ADH also known as arginine vasopressin) which results in:
    • Water retention/ intoxication,
    • Hyponatremia and hypoosmolality

Canadian Cancer Society, 2021

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2024 Nurses International (NI) and the Academic Network. All rights reserved.

5 of 26

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2024 Nurses International (NI) and the Academic Network. All rights reserved.

6 of 26

Incidence of (SIADH)

  • Approximately 67% of SIADH cases are reported to be caused by cancer.
  • The majority of which (70%) are linked to small cell carcinoma of the lung.
  • Head and neck cancers are responsible for only 1.5% of SIADH cases, however, the majority of these cases have the histology of small cell carcinoma.

Yoo et al., 2008

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2024 Nurses International (NI) and the Academic Network. All rights reserved.

7 of 26

Causes of (SIADH)

Cancer Care Nova Scotia, 2014

  • SIADH can be caused by the ectopic production of ADH by tumour tissue.
  • Small cell lung cancer is most often associated with SIADH.
  • Less common malignancies associated with SIADH include:
    • Breast
    • Carcinoid tumours
    • Head and neck
    • Duodenal
    • Esophageal
    • Pancreatic
    • Non-small cell lung cancer
    • Neuroblastoma
    • Ovarian
    • Prostate
    • Thymoma

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2024 Nurses International (NI) and the Academic Network. All rights reserved.

8 of 26

Causes of (SIADH)

Cancer Care Nova Scotia, 2014

  • Other possible causes of SIADH include cytotoxic chemotherapy and agents, including:
    • Cisplatin
    • Cyclophosphamide
    • Ifosfamide
    • Imatinib
    • Melphalan
    • Tricyclic antidepressants
    • Vinca alkaloids (Vinblastine, Vinorelbine, Vincristine, and Vindesine)

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2024 Nurses International (NI) and the Academic Network. All rights reserved.

9 of 26

Pathophysiology of SIADH

SIADH consists of:

  • Hyponatremia
  • Inappropriately elevated urine osmolality (greater than 100 mosm/kg)
  • Decreased serum osmolality in an euvolemic patient (no clinical signs of volume depletion of extracellular fluids)
  • Hyponatremia severity is based on the following levels:
    • Mild: 130–134 meq/L
    • Moderate: 125–129 meq/L
    • Profound: less than 125 meq/L

Tasler & Bruce, 2018

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2024 Nurses International (NI) and the Academic Network. All rights reserved.

10 of 26

Review Question:

Which is the most common cause of SIADH in a cancer patient? (Select the correct answer).

  1. Cancer of head and neck
  2. Small cell carcinoma of lungs
  3. Breast cancer
  4. Duodenal Cancer

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2024 Nurses International (NI) and the Academic Network. All rights reserved.

11 of 26

Sign and Symptoms of SIADH

Tasler & Bruce, 2018

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2024 Nurses International (NI) and the Academic Network. All rights reserved.

12 of 26

Sign and Symptoms of SIADH

Cancer Care Nova Scotia, 2014

  • Early symptoms of SIADH can include:
    • Abdominal cramping
    • Anorexia
    • Ataxia
    • Diarrhea
    • Difficulty concentrating
    • Headache
    • Vomiting
    • Irritability
    • Lethargy
    • Muscle cramps and weakness
    • Nausea
    • Oliguria
    • Thirst
  • Early signs include:
    • Hypoactive reflexes

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2024 Nurses International (NI) and the Academic Network. All rights reserved.

13 of 26

Signs and Symptoms of SIADH

Cancer Care Nova Scotia, 2014

  • Severe hyponatremia (serum sodium < 125 mmol/L) has serious and potentially life threatening consequences, particularly if onset is rapid (within 1-3 days), including:
    • Confusion
    • Hallucinations
    • Delirium
    • Seizures
    • Decerebrate posturing
    • Coma
    • Respiratory arrest

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2024 Nurses International (NI) and the Academic Network. All rights reserved.

14 of 26

What would the nurse do?

Mr. Mehra has a lung carcinoma. He has been treated with the chemotherapy drug called cyclophosphamide. During his hospital stay his serum sodium level was found to be <135 mmol/L. The nurse suspects that he could develop SIADH. What are the early sign and symptoms a nurse would assess for? (Select all that apply).

  1. Oliguria
  2. Muscle cramp
  3. Abdominal crap
  4. Nausea/vomiting

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2024 Nurses International (NI) and the Academic Network. All rights reserved.

15 of 26

Diagnosis of SIADH

Cancer Care Nova Scotia, 2014

Assessment:

  • History:
    • Perform health history
    • Questions about the symptoms
  • Physical and neurological exams:
    • Check the coordination and how well the patient’s muscles and reflexes are working
  • Investigation:
    • Electrolytes
    • Urea
    • Creatinine
    • Serum osmolality
    • Urine osmolality
    • Urine sodium

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2024 Nurses International (NI) and the Academic Network. All rights reserved.

16 of 26

Diagnosis of SIADH

  • Diagnosis of hyponatremia alone is not sufficient to diagnose SIADH
  • Essential features include:
    • Decreased effective serum osmolality (<275 mOsm/kg of water)
    • Urine osmolality >100 mOsm/kg of water during hypotonicity
    • Clinical euvolemia (no evidence of volume depletion or excessive volume of extracellular fluid)
    • Urinary sodium >40 mmol/L with normal dietary salt intake and normal thyroid and adrenal function

Cancer Care Nova Scotia, 2014

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2024 Nurses International (NI) and the Academic Network. All rights reserved.

17 of 26

Management of SIADH

  • Rapid treatment is indicated for symptomatic patients with severe hyponatremia that is known to have developed acutely (within the last 48hrs):
    • 3% Hypertonic Saline IV infusion: Increase serum sodium by 1-2 mmol/L per hour (for the first 3-4 hours, then reduce correction rate to <0.5 mEq/L per hour)
    • Sodium correction should not exceed 8-10 mmol/L in 24 hrs or 18-25 mmol/L in 48 hrs*
    • A central IV line is required for infusions longer than 6h

Cancer Care Nova Scotia, 2014

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2024 Nurses International (NI) and the Academic Network. All rights reserved.

18 of 26

Management of SIADH

  • Patients with hyponatremia of unknown duration and non specific or absent symptoms require more cautious management
    • Modest correction of serum sodium by 0.5-1.0 mmol/L per hour via 0.9% saline infusion
    • Sodium correction should not exceed 8 mmol/L in 24 hrs and 18 mmol/L in 48 hrs
    • Consider use of salt tabs, loop diuretics
  • Rapid correction of serum sodium may cause osmotic demyelination characterized by lethargy, affective changes, mutism, dysarthria, spastic quadraparesis and pseudobulbular palsy

Cancer Care Nova Scotia, 2014

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2024 Nurses International (NI) and the Academic Network. All rights reserved.

19 of 26

Nurse’s Role in SIADH

Tasler & Bruce, 2018

  • Be aware of specific cancers and regimens that may predispose patients to hyponatremia.
  • Assess patients for:
    • Changes in mental status, irritability, headache, confusion, tremors, restlessness, nausea and vomiting, fatigue, and weakness.
    • Patients may present with a low urine output without hypovolemia.
    • Laboratory tests will show low sodium levels and decreased serum osmolality (less than 235 mosm/L).

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2024 Nurses International (NI) and the Academic Network. All rights reserved.

20 of 26

Nurse’s Role in SIADH

Tasler & Bruce, 2018

  • Nurse requires:
    • Close monitoring of intake and output
    • Maintaining fluid restriction
    • Daily weight check
    • Hemodynamic monitoring, and
    • Conducting frequent neurologic checks
    • Monitoring of serum sodium ( as often as every 2-3 hrs) is indicated to avoid rapid or over correction

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2024 Nurses International (NI) and the Academic Network. All rights reserved.

21 of 26

Nurse’s Role in SIADH

Tasler & Bruce, 2018

Emotional and supportive care

  • Educate patients and caregivers on:
    • The side effects of their treatment regimens
    • Specific cancers and regimens that may predispose patients to hyponatremia
    • Recognition of sign and symptoms/ prompt reporting
    • Fluid restrictions
    • High sodium diet
    • Monitor I/O and daily weight check

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2024 Nurses International (NI) and the Academic Network. All rights reserved.

22 of 26

Red Flags

  • Rapid correction of serum sodium may cause osmotic demyelination characterized by lethargy, affective changes, mutism, dysarthria, spastic quadraparesis and pseudobulbular palsy.
  • Clinical management of SIADH in-volves slowly normalizing patients’ sodium level during 24–48 hours. Replacing it too quickly can result in death.

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2024 Nurses International (NI) and the Academic Network. All rights reserved.

23 of 26

Case Study/Critical Thinking Question/What would the nurse do?

Miss Mina is a nurse who is looking after a cancer patient who suddenly developed SIADH. The patient is getting treated with 3% hypertonic saline to correct the hyponatremia and sign and symptoms of SIADH. What interventions are part of the nurse’s role while caring the patient? (Select all that apply).

  1. Monitor Intake output
  2. Daily weight check
  3. Fluid restriction
  4. Hemodynamic monitoring

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2024 Nurses International (NI) and the Academic Network. All rights reserved.

24 of 26

References

  • Yoo, M., Bediako, E. O., & Akca, O. (2008). Syndrome of inappropriate antidiuretic hormone (SIADH) secretion caused by squamous cell carcinoma of the nasopharynx: case report. Clinical and experimental otorhinolaryngology, 1(2), 110–112. https://doi.org/10.3342/ceo.2008.1.2.110

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2024 Nurses International (NI) and the Academic Network. All rights reserved.

25 of 26

References

  • Cancer Care Nova Scotia (2014). Guidelines for the Management of Oncologic Emergencies in Adult Patients – Full Version. © Crown copyright, Province of Nova Scotia.

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2024 Nurses International (NI) and the Academic Network. All rights reserved.

26 of 26

Please go to

My Learning Experience

to provide feedback on your experience.

Thank you, and come back soon!

Contact info: info@nursesinternational.org

© 2013-2024 Nurses International (NI) and the Academic Network. All rights reserved.

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2024 Nurses International (NI) and the Academic Network. All rights reserved.